News

Tim Cook's massive investment has had a decisive impact on Apple's bottom line.

These stocks have led the performance of the S&P 500 in recent years.

This trio has dominated the S&P 500.

The Morning Bull - US Market Morning Update Monday, Jul, 6 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 futures up about 0.4% and E-mini Nasdaq-100 futures up around 1.2%, as investors weigh cooling market anxiety against a packed data week. Volatility gauges like VIX futures are down roughly 2%, which means investors are currently pricing in a calmer trading day. At the same time, the ISM Services PMI, existing home sales, and the Federal Reserve meeting...

Micron and Sandisk have risen for a good reason.

Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. Market leaders have certainly capitalized on outsourcing trends and digital transformation initiatives to boost sales, helping fuel a 13.8% gain for the industry over the past six months - 6.2 percentage points higher than the S&P 500.

Wall Street closed mixed to complete a holiday-shortened week.

Savita Subramanian, head of U.S. equity and quantitative strategy for BofA, doesn’t see “any reason to continue to buy Magnificent Seven or megacap tech stocks that are the capex spenders.”

The stock offers a high yield, but it comes with risks.

U.S. stock futures edged higher in the overnight session ahead of Monday’s open following a strong rally in the prior week.

The signal is named for Warren Buffett, who advised on when it's in scary territory -- such as now.

Gains were concentrated in tech stocks after the Dow closed shy of 53,000.

Gains were concentrated in tech stocks after the Dow closed shy of 53,000.

The major gauges advanced with gains concentrated in tech stocks leading to K-shaped fears

The central bank’s June minutes will be the economic highlight. And Wall Street is looking to build on the past week’s nice gains.

You can't know the one thing you need to know about timing the market.

Bank of America reaffirmed its year-end price target of 7,100 for the S&P 500, representing a 5% drop from the week's closing level.

Three funds dominate the emerging markets ex-China conversation right now, and each one has put meaningful daylight between itself and the S&P 500 so far this year. iShares MSCI Emerging Markets ex China ETF (NASDAQ:EMXC) is up 39% year to date, Freedom 100 Emerging Markets ETF (NYSEARCA:FRDM) is up 41%, and Columbia EM Core ex-China ... 3 iShares ETFs Crushing the S&P 500 by 30 Points in 2026

As the old adage goes, nothing lasts forever.

In a quiet week following America’s big birthday bash, we’ll also see data on service-sector activity and the trade deficit. Next week promises to be busier, with big banks kicking off earnings season.

This leading pipeline operator has a bright future.

These companies serve essential customer needs that don't disappear in a recession, making them resilient stocks to consider even when the markets seem volatile.

A quiet calendar ahead gives the market plenty of space to go off the beaten path this week as investors gear up for the beginning of earnings season.

The Nasdaq and many AI stocks like Sandisk are at key levels. Also watch Apple, SpaceX and Robinhood.

Compare the portfolio concentration, risk profiles, and long-term growth of these two pharma ETFs.

Everyone wants to buy a stake in these companies, and they're more than willing to sell it.

Income investors chasing monthly checks from S&P 500 covered-call ETFs keep landing on the same two tickers: Neos S&P 500 High Income ETF (CBOE:SPYI) and JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI). Both promise high, steady payouts by selling options on large-cap U.S. equities. They look interchangeable on a screener, yet their construction diverges sharply. One ... SPYI vs. JEPI: Which S&P 500 Covered-Call ETF Pays You More Safely?

A major acquisition in the space tech category propelled massive gains for AST stock this week.

Compare cost, diversification, and risk profiles as these two funds take different approaches to North American energy infrastructure exposure.

One offers broad stability with lower costs and higher income, while the other chases biotech growth with 89.3% annual returns but steeper volatility.